Author:
Fadda Giulia,Campus Guglielmo,Lugliè PierFranca
Abstract
Abstract
Background
We describe the risk indicators for oral mucositis (OM) in paediatric oncology patients hospitalised in the Institut Gustave Roussy (Villejuif-Paris) and treated with alkylant chemotherapy with autologous peripheral blood progenitor cells.
Methods
The sample was selected using PIGAS software. Three groups of subjects received different chemotherapy regimens: A. Melphalan, B. Busulfan and C. other alkylant protocols. The degree of mucositis was recorded by CTC version 2.0 (Common Toxicity Criteria). Descriptive statistics were performed. The association between mucositis and risk indicator variables was tested using a χ2 test. The association between case status and covariates was tested using unconditional logistic regression analysis.
Results
Of the 337 children enrolled, 241 showed mucositis (group 1) and 96 did not show mucositis (group 2) during alkylant chemotherapy. There was a higher prevalence of male patients in both groups. The three different chemotherapy regimen groups are correlated with the appearance of oral mucositis (χ2 = 22.42, p < 0.01). Weight loss was higher in group 1 (χ2 = 6.31, p = 0.01). The duration of aplasia was lower in the Busulfan protocol (7.5 days) than in the Melphalan group (9.3 days) or the other regimens (8.6 days). The use of Bufulfan® was directly associated with case status (presence of oral mucositis): odds ratio [OR] = 2.1 and confidence interval [95%CI] = 1.3–3.0. Also, occurrences of germinal tumours and secondary bacterial infections were directly linked with case status: [OR] = 1.4 and 1.8, confidence interval [95%CI] = 1.2 – 1.7 and 1.1 – 2.5, respectively.
Conclusion
The presence of OM was associated with the three different chemotherapy regimens considered; in particularly patients treated with Busulfan had the highest prevalence.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Raber-Durlacher JE, Epstein JB, Bresters D, Stern-Zivan L: Oral complications in children with cancer. Eur J Paediatric Dent. 2005, 3: 3-12.
2. Szpirglas H, Deszcz-Thomas A, Lacoste JP: Chemiothérapie des cancers. Encycl Méd Chir Stomatologie. 1997, 22-65.
3. Wojtaszek C: Management of chemotherapy-induced stomatitis. Clinical Journal of Oncology Nursing. 2000, 4: 263-270.
4. Wardley AM, Jayson GC, Swindell R, Morgenstern GR, Chang J, Bloor R, Fraser CJ, Scarffe JH: Prospective evaluation of oral mucositis in patient receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Brit J Haematol. 2000, 110: 292-299. 10.1046/j.1365-2141.2000.02202.x.
5. Squier CA, Kremer MJ: Biology of oral mucosa and esophagus. J National Cancer Inst Monographs. 2001, 29: 7-15.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献